Search - tctmd.com

Displaying 701 - 720 of 962

Sort: Relevancy | Date

News Industry News

Philips and RealView Imaging conclude world’s first study to evaluate live 3D holographic imaging in interventional cardiology

October 28, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

Presentation TCT 2013

Status Update on the Randomized Moderate Risk AS Trials: PARTNER 2A

Presenter: Martin Leon

October 27, 2013

Presentation TCT 2013

PARTNER A (Surgery vs. TAVR at 2 Years): Essential Results

Presenter: Martin Leon

October 27, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Industry News

Creganna-Tactx Medical to Showcase Expertise in Emerging Medical Therapies at TCT 2013

October 22, 2013

News Daily News

中度/重度二尖瓣返流TAVR患者的预后更差

October 11, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

October 11, 2013

News Daily News

Transfemoral Access Not Only Option for TAVR

Yael L. Maxwell

October 04, 2013

News Daily News

El Abordaje Transfemoral No es la Única Opción para la TAVR

Yael L. Maxwell

October 04, 2013

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

News Daily News

Meta Análisis: A las Mujeres les Va Mejor que a los Hombres tras una TAVR a pesar de tener Más Complicaciones

Yael L. Maxwell

September 27, 2013

News Daily News

Marriage Linked to Better PCI Outcomes

Yael L. Maxwell

September 27, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

Presentation ESC 2013

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Presenter: Brian R. Lindman

September 03, 2013

News Daily News

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Jason Kahn

August 12, 2013

Advertisement

Philips and RealView Imaging conclude world’s first study to evaluate live 3D holographic imaging in interventional cardiology

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

Status Update on the Randomized Moderate Risk AS Trials: PARTNER 2A

PARTNER A (Surgery vs. TAVR at 2 Years): Essential Results

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

Creganna-Tactx Medical to Showcase Expertise in Emerging Medical Therapies at TCT 2013

中度/重度二尖瓣返流TAVR患者的预后更差

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

Transfemoral Access Not Only Option for TAVR

El Abordaje Transfemoral No es la Única Opción para la TAVR

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Meta Análisis: A las Mujeres les Va Mejor que a los Hombres tras una TAVR a pesar de tener Más Complicaciones

Marriage Linked to Better PCI Outcomes

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content